These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19301827)

  • 21. Principles, implementation, and application of biology-oriented synthesis (BIOS).
    Wilk W; Zimmermann TJ; Kaiser M; Waldmann H
    Biol Chem; 2010 May; 391(5):491-7. PubMed ID: 20030592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.
    Torre BG; Albericio F
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of flavonoid analogues as scaffolds for natural product-based combinatorial libraries.
    Yao N; Song A; Wang X; Dixon S; Lam KS
    J Comb Chem; 2007; 9(4):668-76. PubMed ID: 17487987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery.
    Kombarov R; Altieri A; Genis D; Kirpichenok M; Kochubey V; Rakitina N; Titarenko Z
    Mol Divers; 2010 Feb; 14(1):193-200. PubMed ID: 19468851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of an anthraquinone and chalcone derivatives-based virtual combinatorial library. A cheminformatics "proof-of-concept" study.
    Moshawih S; Hadikhani P; Fatima A; Goh HP; Kifli N; Kotra V; Goh KW; Ming LC
    J Mol Graph Model; 2022 Dec; 117():108307. PubMed ID: 36096064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds.
    Isidro-Llobet A; Hadje Georgiou K; Galloway WR; Giacomini E; Hansen MR; Méndez-Abt G; Tan YS; Carro L; Sore HF; Spring DR
    Org Biomol Chem; 2015 Apr; 13(15):4570-80. PubMed ID: 25778821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principle and design of pseudo-natural products.
    Karageorgis G; Foley DJ; Laraia L; Waldmann H
    Nat Chem; 2020 Mar; 12(3):227-235. PubMed ID: 32015480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Fragment Library of Natural Products and its Comparative Chemoinformatic Characterization.
    Chávez-Hernández AL; Sánchez-Cruz N; Medina-Franco JL
    Mol Inform; 2020 Nov; 39(11):e2000050. PubMed ID: 32302465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries.
    Wenderski TA; Stratton CF; Bauer RA; Kopp F; Tan DS
    Methods Mol Biol; 2015; 1263():225-42. PubMed ID: 25618349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and Synthesis of Natural Product Inspired Libraries Based on the Three-Dimensional (3D) Cedrane Scaffold: Toward the Exploration of 3D Biological Space.
    Mazraati Tajabadi F; Pouwer RH; Liu M; Dashti Y; Campitelli MR; Murtaza M; Mellick GD; Wood SA; Jenkins ID; Quinn RJ
    J Med Chem; 2018 Aug; 61(15):6609-6628. PubMed ID: 30005573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysing and Navigating Natural Products Space for Generating Small, Diverse, But Representative Chemical Libraries.
    O'Hagan S; Kell DB
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 29168302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural product-likeness score and its application for prioritization of compound libraries.
    Ertl P; Roggo S; Schuffenhauer A
    J Chem Inf Model; 2008 Jan; 48(1):68-74. PubMed ID: 18034468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ternary resin-bound Dynamic Combinatorial Chemistry.
    Gromova AV; Ciszewski JM; Miller BL
    Chem Commun (Camb); 2012 Feb; 48(15):2131-3. PubMed ID: 22240966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Combinatorial Fragment Spaces and Its Application to Ultralarge Make-on-Demand Compound Catalogs.
    Bellmann L; Penner P; Gastreich M; Rarey M
    J Chem Inf Model; 2022 Feb; 62(3):553-566. PubMed ID: 35050621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creating the New from the Old: Combinatorial Libraries Generation with Machine-Learning-Based Compound Structure Optimization.
    Podlewska S; Czarnecki WM; Kafel R; Bojarski AJ
    J Chem Inf Model; 2017 Feb; 57(2):133-147. PubMed ID: 28158942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the scaffold diversity of screening libraries.
    Krier M; Bret G; Rognan D
    J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.